Zanetti S - Search Results

1

Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.

Carta A, Loriga M, Paglietti G, Mattana A, Fiori PL, Mollicotti P, Sechi L, Zanetti S. Carta A, et al. Among authors: zanetti s. Eur J Med Chem. 2004 Feb;39(2):195-203. doi: 10.1016/j.ejmech.2003.11.008. Eur J Med Chem. 2004. PMID: 14987828

2

Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.

Carta A, Paglietti G, Rahbar Nikookar ME, Sanna P, Sechi L, Zanetti S. Carta A, et al. Among authors: zanetti s. Eur J Med Chem. 2002 May;37(5):355-66. doi: 10.1016/s0223-5234(02)01346-6. Eur J Med Chem. 2002. PMID: 12008050

3

Quinoxalin-2-ones. Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl- and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety.

Carta A, Loriga M, Zanetti S, Sechi LA. Carta A, et al. Among authors: zanetti s. Farmaco. 2003 Dec;58(12):1251-5. doi: 10.1016/S0014-827X(03)00198-8. Farmaco. 2003. PMID: 14630235

4

[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.

Carta A, Palomba M, Paglietti G, Molicotti P, Paglietti B, Cannas S, Zanetti S. Carta A, et al. Among authors: zanetti s. Bioorg Med Chem Lett. 2007 Sep 1;17(17):4791-4. doi: 10.1016/j.bmcl.2007.06.064. Epub 2007 Jun 26. Bioorg Med Chem Lett. 2007. PMID: 17604166

5

Synthesis and anti-mycobacterial activities of triazoloquinolones.

Carta A, Palomba M, Briguglio I, Corona P, Piras S, Jabes D, Guglierame P, Molicotti P, Zanetti S. Carta A, et al. Among authors: zanetti s. Eur J Med Chem. 2011 Jan;46(1):320-6. doi: 10.1016/j.ejmech.2010.11.020. Epub 2010 Nov 19. Eur J Med Chem. 2011. PMID: 21145625

6

Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.

Carta A, Bua A, Corona P, Piras S, Briguglio I, Molicotti P, Zanetti S, Laurini E, Aulic S, Fermeglia M, Pricl S. Carta A, et al. Among authors: zanetti s. Eur J Med Chem. 2019 Jan 1;161:399-415. doi: 10.1016/j.ejmech.2018.10.031. Epub 2018 Oct 17. Eur J Med Chem. 2019. PMID: 30384044 Free article.

7

Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.

Loriga M, Moro P, Sanna P, Paglietti G, Zanetti S. Loriga M, et al. Among authors: zanetti s. Farmaco. 1997 Aug-Sep;52(8-9):531-7. Farmaco. 1997. PMID: 9507661

8

Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity.

Sanna P, Carta A, Loriga M, Zanetti S, Sechi L. Sanna P, et al. Among authors: zanetti s. Farmaco. 1998 Jul 30;53(7):455-61. doi: 10.1016/s0014-827x(98)00044-5. Farmaco. 1998. PMID: 9836457

9

Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3.

Sanna P, Carta A, Loriga M, Zanetti S, Sechi L. Sanna P, et al. Among authors: zanetti s. Farmaco. 1999 Mar 31;54(3):169-77. doi: 10.1016/s0014-827x(99)00011-7. Farmaco. 1999. PMID: 10371030

10

Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.

Carta A, Sanna P, Gherardini L, Usai D, Zanetti S. Carta A, et al. Among authors: zanetti s. Farmaco. 2001 Dec;56(12):933-8. doi: 10.1016/s0014-827x(01)01161-2. Farmaco. 2001. PMID: 11829113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters